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ABSTRACT  Thrombospondin, a high molecular weight glycoprotein secreted by platelets in response 
to activation by thrombin, has been identified by immunofluorescence in bovine aortic endothelial 
cells,  human  foreskin  fibroblasts,  and  human  aortic  smooth  muscle  cells.  Immunofluorescence 
patterns were  found  to  be  similar using antisera  raised  to  thrombospondins purified  either from 
bovine aortic endothelial cells or from  human platelets. Radioimmune precipitation of pulse-labeled 
cellular proteins confirmed the presence of thrombospondin in  positively stained cells. A  sensitive 
quantitative enzyme-linked immunosorbent assay (ELISA) was developed and used to determine that 
the accumulation of secreted thrombospondin was similar for endothelial cells and fibroblasts but 
was higher for smooth  muscle cells. The presence of thrombospondin in a variety of cells suggests 
that its function may not be limited to an involvement in platelet interactions. 
Thrombospondin (TS), a high molecular weight glycoprotein, 
is  released  from  a-granules  after  activation  of platelets  by 
thrombin (1, 2). After release, the protein binds to the activated 
platelet surface in a  calcium-dependent  fashion (3) and may 
participate in platelet-platelet interactions (4).  Earlier work in 
this laboratory (5) identified a high molecular weight glycopro- 
tein secreted by endothelial cells in culture that represented a 
substantial portion of the noncollagenous protein synthesized 
and secreted by these cells. This glycoprotein was subsequently 
shown to be indistinguishable from TS by a variety of criteria, 
including co-purification, molecular weight,  amino acid com- 
position, immunological cross-reactivity, and peptide maps (6). 
Although  TS has been shown to have lectinlike activity in 
platelet-platelet interactions (4), its function in endothelial cells 
is not known. This led us to examine other cells in culture for 
the synthesis and secretion of TS. We have now identified TS 
in  a  variety of mesenchymal cells.  Since  TS is secreted  and 
deposited in the cell layer of these cells in culture, we postulate 
that it may function as a matrix protein in vivo. 
MATERIALS  AND  METHODS 
Cell Culture 
Bovine aortic endothelial (BAE) ceils were provided by Dr.  S.  Schwartz 
(University of Washington).  They  were maintained in Waymouth's medium 
supplemented with  10%  fetal calf serum (FCS)  (Reheis Chemical Company, 
Phoenix, AZ), penicillin (100 U/nil), and streptomycin (100 gg/ml). Human 
dermal  fibroblasts  were  isolated from  foreskin explants and  maintained  in 
Dulbecco's modified Eagle's medium (DME) supplemented with 10% FCS and 
antibiotics. Smooth muscle ceils were obtained from human aortae and were 
provided by Dr. Russell Ross (University of Washington). They were maintained 
in DME supplemented with 20% FCS and antibiotics. Ceils were grown at 37°C 
in an atmosphere of 5% CO2. 
Purification of Thrombospondins 
BAE cell TS was isolated according to the method of McPherson el al. (6). 
Human platelet TS was isolated from l-d-old blood bank platelets according to 
the procedure  of Lawler and Slayter (7),  with modifications. 4  U  of washed 
platelets were harvested by centrifugation and suspended in a buffer containing 
20 mM Tris-HC1,  150 mM NaC1,  5 mM KC1, 5 mM a-D-glucose, and 2.5 mM 
EDTA, pH 7.5. Alpha granule contents were released after activation by human 
thrombin (3.5  National Institutes of Health ('NIH) U/ml) for  15 rain at room 
temperature with stirring. Thrombin was inactivated by adding phenylmethyl- 
sulfonyl fluoride (PMSF)  to a  final concentration of 0.2  mM.  Platelets were 
removed by centrifuging at 27,000 g for 20 min at 4°C. The supernatant fraction 
was applied to a Sepharose CL-4B column (2.5 x  100 cm) equilibrated in a buffer 
containing 20  mM  Tris-HCl;  150  mM  NaC1,  and  2.5  mM  EDTA,  pH  7.5. 
Fractions were monitored by absorbance at 280 nm; fractions containing TS were 
pooled and gently shaken for 2 h at 4°C with heparin-Sepharose 6B. A column 
was poured with the gel, washed with a buffer containing 20 mM Tris-HCl, 150 
mM NaC1, pH 7.5, and the TS eluted with a buffer containing 20 mM Tris-HCl, 
600 mM NaC1, pH 7.5. Typical yields were ~3 mg with peak concentrations of 
1 mg/ml. Bovine platelet TS was prepared essentially as described above. 
Preparation of Antisera 
Rabbit antisera were raised to BAE cell TS and human platelet TS.  Rabbit 
IgG was purified by repeated ammonium sulfate precipitation and was assayed 
by an ELISA method.  Human yon WiUebrand's factor and a2-macroglobulin 
were provided by Drs. Michael Chopek and Mark Lively (University of Wash- 
ington), respectively; human fibronectin was purchased from Collaborative Re- 
search (Waltham,  MA);  mouse laminin was provided by Dr.  George Martin 
(National Institutes of Health) and Dr. Atsuhiko Oohira (University of Washing- 
ton). Collagens and procollagens from human or bovine tissue were prepared by 
standard methods as described by Sage and Borustein (8). Contaminating activ- 
ities were  removed  by  affinity chromatography  with  Sepharose  4B-coupled 
ligands. 
Immunofluorescence Microscopy 
Cells were grown to confluence on glass microscope slides or cover slips. They 
were fixed in neutral buffered paraformaldehyde (3%)  and permeabliized in 
absolute ethanol at -70°C for 15 s when appropriate. Cells were then exposed to 
antiserum (l:10)  for  30  rain  at  37°C,  washed,  and  exposed  to  fluorescein- 
conjugated goat antirabbit IgG (Miles-Yeda Ltd., Rehovot, Israel) at 1:20 dilution 
for 30 min at 37°C. 
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Cells grown in standard medium were washed twice in serum-free Waymouth's 
medium minus cysteine and incubated at 37°C in the presence of 100 #Ci/ml 
~S-cysteine (New England Nuclear, Boston, MA; 937 Ci/mmol). The medium 
was discarded and the  cells were washed three  times with ice-cold PBS and 
harvested in  PBS containing 0.5% deoxycholate, 0.5% Triton X-100, 0.2 mM 
PMSF,  and  10 mM  N-ethylmaleimide (NEM).  After vortexing, the insoluble 
debris was removed by a briefcentrifugation. Aliquots of  the supernatant fraction 
(100-200/~1) were transferred to microfuge tubes precoated with a  solution of 
0.1% bovine serum albumin (BSA),  and  l0 #1 of antiserum was added. The 
mixture was allowed to stand for 1-2 h  at room temperature, then 100/~1 sheep 
anti-rabbit IgG was added, and the mixture was allowed to stand for another 2 
h. The precipitate was washed three times  in PBS containing detergents and 
protease inhibitors and once in PBS before being dissolved in 0.01  N  HC[ and 
neutralized with NaOH. The sample was then boiled in  SDS  electrophoresis 
sample buffer with reducing agent and subjected to SDS PAGE. 
Quantitative ELISA 
Human TS,  t #g/ml of PBS, was used to coat Immulon I 96-well microtiter 
plates (Dynatech Laboratories, Inc., Alexandria, VA). All dilutions of antiserum 
and TS were made in a buffer containing 150 mM NaCI, 1.5 mM KHzPO4, 10.8 
mM Na2HPO,, 2.7 mM KC1, 0.05% Tween 20, @02% NaNo, and 1 mg/ml BSA. 
Antiserum was diluted 314-fold; TS was diluted to concentrations in the range of 
0-1,000 ng/ml. Absorption of antiserum was accomplished by incubating 110 #1 
of diluted antiserum with  1  l0 #1 of TS at different concentrations in uncoated 
microtiter wells for 1 h at 37°C. 200 #1 of each solution was withdrawn, added to 
appropriate wells of coated microtiter plates, and incubated for 30 rain at 37°C. 
The plates were then washed with a solution containing 0.15 M NaC1 and @05% 
Tween  20.  Alkaline  phosphatase-conjugated goat anti-rabbit IgG (200 #l  of 
l: 1,000 dilution) (Miles Laboratories, Inc., Elkhart, IN) was added to each well 
and incubated for 4-6 h at room temperature. The plates were washed as before, 
drained, and 200 #1 of p-nltrophenyl phosphate (1 rag/m1 in 1 M diethanolamine, 
pH 9.8) was added. After a  15-min incubation at room temperature, the reaction 
was stopped by adding 50 #1 of l  M  NaOH. Optical density in each well was 
measured with a Dynatech plate scanner at 400 am. Samples containing  unknown 
amounts of TS were diluted with the above buffer into the concentration range 
measurable by the assay, preincubated with antibody in parallel with TS stand- 
ards, and then incubated with TS-coated plates. Each sample was assayed in 
duplicate at two or more concentrations. 
Quantification of Thrombospondin  in 
Culture Media 
CeiLs were grown to confluence in 12-well Costar tissue culture plates (Costar, 
Data Packaging, Cambridge, MA) containing I ml of 5% heat-inactivated porcine 
serum in Waymouth's medium. At the start of the measurement, the medium 
was replaced with 0.6 ml of fresh medium containing 1% serum; after 18 h, 0.5 
ml of the medium was transferred to a 1.5-ml microfuge tube containing 0.05 ml 
of an inhibitor solution (250 mM EDTA,  100 mM NEM, and 2 mM PMSF) at 
4°C. The sample was centrifuged to pellet any ceils, and the supernatant fraction 
was diluted in buffer for quantification of TS by the ELISA method. The cell 
layer was trypsinized and cell number was determined by electronic counting. 
Since the antisera were raised to thrombospondins of differ- 
ent species, it was of interest to know whether antiserum raised 
against bovine endothelial cell TS reacted with human TS, and 
vice versa. Fig.  1 shows the results of quantitative assays using 
the bovine  and human proteins. The anti-bovine  endothelial 
cell TS reacted equally well with human or bovine TS (Fig.  1 
A). However, a greater amount of bovine compared to human 
TS was required to achieve the same degree of inhibition of 
the reaction of anti-human TS with its antigen (Fig. 1 B). Thus 
the anti-human TS serum shows some species specificity and 
reacts better with the human than with the bovine antigen. 
Immunofluorescence Microscopy 
Representative  fluorescence  micrographs  of bovine  aortic 
endothelial cells, human foreskin fibroblasts, and human aortic 
smooth muscle cells are shown in Fig. 2.  Cells were permea- 
bilized and stained with either anti-BAE cell TS or anti-human 
platelet TS, followed by staining with fluorescein-conjugated 
goat  anti-rabbit  IgG.  A  prominent  pattern  of  granules  of 
intracellular  fluorescence  in  a  perinuclear  distribution  was 
present in all three cell types using either antiserum. In addi- 
tion, some extracellular matrix staining ofa fibrillar nature was 
observed. Only the fibriUar  pattern was seen in cells that were 
not permeabilized. In other experiments we showed that the 
extracellular fluorescence was not due to trapping or adsorption 
of TS from serum contained  in culture medium, because the 
same pattern of extracellular fluorescence was seen when cells 
were grown in medium containing pig serum; porcine TS was 
not detected by anti-human or anti-bovine TS (see below). 
The pattern of intracellular staining for TS was the same as 
that for fibronectin  but the extracellular staining was clearly 
different from the pattern for fibronectin (9).  Parallel experi- 
ments  using  affinity-purified  rabbit  anti-human  fibronectin 
antibodies  showed  that  absorption  of anti-TS  sera  with  an 
amount of fibronectin sufficient to prevent the appearance of 
fluorescence due to fibronectin in endothelial cells and fibro- 
blasts  had  no  effect  on  the  fluorescence  due  to  TS.  On  the 
other hand, preincubation ofanti-TS serum with human plate- 
let TS inhibited the appearance of fluorescence in endothelial 
cells and fibroblasts. No fluorescence was seen when a preim- 
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RESULTS 
Purification and Characterization  of Antisera 
Rabbit  anti-bovine  endothelial  ceil  TS  contained  activity 
against bovine and human TS, human a2-macroglobulin and 
mouse laminin. The contaminating activities were removed by  ~  0 
absorption with a2-macroglobulin-Sepharose 4B and Iaminin-  i 
Sepharose 4B. By analysis using the direct ELISA method, the  .~  lO0 
purified antiserum reacted with thrombospondin but not with  ~  so 
human  type  I,  type  III, or type V  collagen,  bovine  type  III  .~ 
procollagen,  or  type  IV  collagen,  von  WiUebrand's  factor,  ~t  so- 
fibronectin, or fibrinogen (data not shown). Rabbit anti-human 
40- 
platelet  TS  had  activity  against  human  and  bovine  TS  and 
fibronectin.  The  contaminating  activity was removed by  ab-  2o. 
sorption with fibronectin-Sepharose 4B; the purified antiserum 
reacted only with TS and not with any of the other antigens 
mentioned above, as analyzed by ELISA. 
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A  FIGURE  1  Character- 
ization  of  antisera  to 
thrombospondins  by 
ELISA.  (A)  Standard 
curves developed using 
anti-bovine  aortic  en- 
dothelial  cell  TS  react- 
ing  with  microtiter 
plates coated with  hu- 
,  ,  ,  ,  man TS. The competing 
antigen was: (0) Bovine 
B  platelet TS. (©)  Human 
platelet TS.  (B)  Stand- 
,.o-  ,  ard  curves  developed 
using  anti-human 
patelet  TS  reacting 
with  microtiter  plates 
coated with  human TS. 
The competing antigen 
was: (O) Bovine platelet 
TS. (O)  Human platelet 
i  i  i  I 
1  10  100  t,O00  TS. 
Thrombospondin  (no/ml) cells, fibroblasts, and smooth muscle cells comigrated on SDS 
slab gels with a human platelet TS standard. The band below 
TS in lanes c andf (Fig. 3) may correspond to the derivative 
of TS noted by McPherson et al. (6). 
Quantification  of  Thrombospondin 
TS  levels were  measured  by  ELISA in  the  sera of seven 
individuals aged 22-53. Blood was collected and placed in glass 
tubes at room temperature for 2 h  and then at 4°C overnight. 
The  value  obtained  was  15.3  _  4.0  /zg/ml.  There  was  no 
obvious sex or age dependence of the  serum content of TS. 
There was no interference from other serum proteins, since TS 
was  accurately  measured  in  bovine  plasma-derived  serum 
(which contains <1  /~g/ml of TS) when the purified protein 
was deliberately added to it. These findings are in agreement 
with those in a recently published paper (10). A sample of fetal 
calf serum was analyzed for TS on nine different days and a 
value of 31.6 +  4.6/xg/ml was obtained. No immunodetectable 
TS (<0.02/xg/ml) was found in sera of swine, horses, chickens, 
or  mice.  This  finding  almost  certainly  reflects  the  species 
specificity of the antiserum used. 
Quantification of TS levels in  the  media of cultured cells 
(Table I) indicated that both fibroblasts and  smooth muscle 
FIGURE  2  Fluorescence  microscopy.  Cells  were cultured  on  glass 
slides,  fixed and  permeabilized, exposed to anti-TS antiserum  fol- 
lowed by staining with fluorescein-conjugated goat anti-rabbit IgG. 
(A)  Bovine  endothelial  cells  treated  with  anti-BAE  cell  TS.  (B) 
Human foreskin fibroblasts treated with anti-human platelet TS. (C) 
Human aortic smooth muscle cells treated with anti-human platelet 
TS. x  400. 
mune  antiserum  was  used  or  when  the  first  antibody  was 
omitted and only the goat anti-rabbit IgG was used.  Human 
epidermoid carcinoma cells (A431) and a human leukemia cell 
line (K562) were negative for TS by immunofluorescence (data 
not shown). 
Radio-immune  Precipitation 
To confirm the presence of TS in cultured ceils, precipitation 
of radio-labeled cultures with anti-BAE cell or human platelet 
TS  was  performed.  As  shown  in  Fig.  3,  the  predominant 
protein precipitated by the antiserum in lysates of endothelial 
FIGURE  3  Autoradiograms of SDS slab gels. Anti-TS serum was used 
to precipitate proteins from lysates of cells labeled with 35S-cysteine. 
(Lanes  a-c)  Human  fibroblasts  labeled for  1  h:  a,  cell  lysate;  b, 
precipitate with preimmune serum;  c, precipitate with anti-BAE cell 
TS serum.  (Lanes  d-f)  Human  fibroblasts labeled for 4  h:  d, cell 
lysate;  e, precipitate with preimmune serum;  f, precipitate with anti- 
BAE cell TS serum. (Lanes g-i) Human smooth muscle cells labeled 
for 30 min:  g, cell lysate;  h,  precipitate with  preimmune serum;  i, 
precipitate with anti-human platelet TS serum.  (Lanes j  and k)  BAE 
cells labeled for 45  rain:  j, cell lysate;  k,  precipitate with  anti-BAE 
cell TS serum.  TS indicates the  position of  migration of  a human 
platelet TS standard. 
TABLE  I 
Thrombospondin Levels  in Cell Culture Medium * 
Thrombo-  Cell density; 
spondin;  cells/cm  2 x 
Cell type  ng/104 cells  10  -4 
Bovine aortic endothelial cells  10 _  3.21-  8.9 +  0.61- 
Human fetal fibroblasts  25 ±  3.8  4.7 ±  0.1 
Human smooth muscle cells  71  +  13  4.1 +  0.5 
* The  results represent quantities  accumulated during  an  18-h period  as 
measured by ELISA. Standard curves were generated using an anti-human 
platelet TS serum and either bovine or human TS. 
"J'± SD (n = 3). 
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Preliminary  experiments  indicate  that  the  concentration  of 
secreted TS for all three ceil types varies inversely with cell 
density. 
DISCUSSION 
Thrombospondin,  a  high  molecular  weight  glycoprotein  of 
unknown function, was first identified in platelets (1-3) and a 
very similar and possibly identical protein was then shown to 
be synthesized by bovine aortic (5,  6) and human umbilical 
vein (11) endothelial ceils. A variety of other endothelial cells 
also synthesize the protein (12). The presence of thrombospon- 
din in both endothelial cells and platelets suggested the possi- 
bility that the protein might function in activities of a vascular 
nature (6,  11). Indeed, evidence has recently been presented in 
support  of a  role  for  TS  as  an  endogenous  lectin  in  the 
aggregation of human platelets (4), possibly by interaction with 
surface membrane-bound fibrinogen (4,  13). The t'mdings re- 
ported here, which show that fibroblasts and smooth muscle 
cells  also synthesize and  secrete  TS,  oblige us to consider a 
broader function for this protein. This is also suggested by the 
presence of the immunoreactive TS in the extracellular matrix 
of cultured ceils (Fig. 2). 
Although it was difficult to purify TS from either platelets 
or endothelial cells and  to obtain  monospecific antisera,  the 
following evidence supports our contention that we have iden- 
tiffed TS both by immunofluorescence and by immunoprecip- 
itation. (a) Both the absorbed anti-BAE cell TS and the anti- 
human platelet TS sera reacted only with TS and not with any 
of many  other  possible  antigens  as  tested  by  ELISA.  (b) 
Immunofluorescence  patterns  were  the  same  with  antisera 
prepared to antigens derived from very different sources (en- 
dothelial cells and platelets) and therefore likely to be contam- 
inated by very different proteins; specific immunofluorescence 
was inhibited  by preabsorption of antisera with purified TS. 
(c) Immunoprecipitation of radio-labeled proteins from three 
different  ceil  types  with  purified  immune  reagents  yielded 
essentially a single band identified as TS by SDS PAGE. 
The quantitative ELISA for TS that we have developed can 
detect  the  protein  at  levels  as  low  as  10  ng/ml,  is  highly 
reproducible in the range of 25-500 ng/ml and is not interfered 
with by other proteins. These characteristics are very similar to 
those of the radioimmunoassay recently developed by Saglio 
and Slayter (10) and the human serum TS level reported by 
these workers, 15.7 +  6.2 #g/ml, is essentially the same as that 
found by us. These values, however, differ from that found by 
Mosher et al.  (11) who have developed a  radioimmunoassay 
that uses protein A-beating Staphylococci "armed" with anti- 
TS IgG. These workers reported a  human serum level of 65 
+  23  #g/ml and  measured  levels of TS secreted  by human 
umbilical vein endothelial ceils  in the range of 490 +  40 ng/ 
104 cells/24 h. These values are likely to be overestimates and 
may have resulted from the limited sensitivity of the method, 
which was reported to be 700 ng/ml (11). 
The presence of TS in both endothelial cells and platelets 
was compatible with the possibility that endothelial cells rep- 
resented the source of platelet  TS. Uptake from plasma may 
be a source for platelet fibronectin, although the issue remains 
to be settled (9).  However, the low plasma TS level,  20-300 
ng/ml (10), makes uptake from plasma less likely for TS. We 
have recently demonstrated TS in megacaryocytes by immu- 
nofluorescence examination of human bone marrow spreads 
(unpublished observations). The synthesis of TS may therefore 
be shared by a wide variety of cells. 
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